Eating
Anorexia Nervosa
search
Anorexia Nervosa
See Also
Refeeding Syndrome
Eating Disorder
Bulimia Nervosa
Avoidant-Restrictive Food Intake Disorder
(
ARFID
)
Epidemiology
Incidence
: 0.5 to 1.0% of adolescents
Lifetime
Prevalence
: 1 per 200 females in U.S. (much more common than
Anorexia
)
Onset in adolescence and continues until early 20's
Age 12 to 25 years old accounts for 95% of cases
Affects women much more often than men by ratio of 10:1
Incidence
in males has been increasing
Risk Factors
Associated personality traits
Food and appearance regulation is under the patient's control
Perfectionist
Obsessive-Compulsive Personality
Socially withdrawn
High achiever
Values success and external rewards
Symptoms
Weight loss
Fatigue
or weakness
Amenorrhea
Constipation
Headache
Cold intolerance
Epigastric Pain
Abdominal Bloating
Appetite remains normal
Morbid fear of fatness
Disturbed body image (Feel fat when thin)
Concern about weight leads to behavior changes
Dieting
Excessive and compulsive
Exercise
routines regardless of illness, injury or weather conditions
Diuretic
or
Laxative
abuse
Binge Eating
may occur in 50% of cases
Ritual behaviors (e.g.
Hand Washing
)
Hides disordered eating from others
Surreptitious mealtime behavior
Wearing of baggy clothes
Avoids food related behavior (skips meals)
Limits diet to vegetables, fruit and diet products
Cuts food into small pieces or picks food apart
Signs
Cachexia
(bone showing through)
Acrocyanosis
Weight 15% below
Ideal Weight
Skin changes
Carotene pigment (yellow discoloration of skin)
Lanugo hair (fine hair on back and cheeks)
Hair Loss
Dry Skin
Delayed
Wound Healing
Induced
Vomiting
signs
Calluses at
Fingernail
s
Chipmunk cheeks (parotid hypertrophy)
Dental enamel erosion
Severe
Anorexia
(starvation signs)
Edema
Bradycardia
Hypothermia
Orthostatic Hypotension
Hypoglycemia
Cognitive Impairment
(typically subtle)
Loss of strength and endurance
Results in slowed movement and decreased athletic performance
Evaluation Tools
See
SCOFF Questionnaire
Diagnosis
DSM V
Major Criteria
Significantly low body weight
Secondary to restriction of
Energy Intake
relative to requirements
Low weight defined in the context of age, gender, developmental trajectory and physical health
Intense fear of fatness or weight gain
May also be met by persistent behavior interfering with weight gain
Persists despite being at a significantly low weight
Disturbed body self image
Abnormal influence of weight or shape on self evaluation or
Lack of recognition of low body weight seriousness
Subtypes (refers to the last 3 months)
Restricting Type
No Binging and purging (see below)
Excessive weight loss achieved through dieting,
Fastin
g or excessive
Exercise
Binge and Purge Type
Self-induced
Vomiting
or
Laxative
,
Diuretic
or enema use or binge-eating
Remission Criteria
Partial Remission
Previously met full major criteria for
Anorexia
Now does not meet significantly low body weight for sustained period
However does have either intense fear of fatness/weight gain OR disturbed body image
Full Remission
Previously met full major criteria for
Anorexia
Now meets none of the major criteria for
Anorexia
Severity (for adults, use BMI percentiles for children and adolescents)
Mild
BMI >17 kg/m2
Moderate
BMI 16-17 kg/m2
Severe
BMI 15-16 kg/m2
Extreme
BMI <15 kg/m2
References
(2013) DSM V, APA, Washington
Differential Diagnosis
Other
Eating Disorder
(i.e.
Bulimia
)
Hyperthyroidism
Addison's Disease
Diabetes Mellitus
Malignancy
Inflammatory Bowel Disease
Immunodeficiency
Malabsorption
Chronic infections
Associated Conditions
Amenorrhea
Osteoporosis
(including
Stress Fracture
s)
Overuse injuries
Female Athlete Triad
Psychiatric illness
Suicidality
Major Depression
Anxiety Disorder
Somatization Disorder
Substance Abuse
Obsessive-Compulsive Disorder
Personality Disorder
(Cluster C - avoidant, anxious)
Social withdrawal
Labs
Complete Blood Count
Leukopenia
Comprehensive Metabolic Panel
Hypoglycemia
Hypochloremic
Metabolic Alkalosis
Hypokalemia
Transaminases increased
Serum Phosphorus
Serum Magnesium
Thyroid Stimulating Hormone
TSH decreased
Normal
Free T4
and
Free T3
Urinalysis
Increased
Urine Specific Gravity
Increased
Urine Ketone
s
Decreased
Urine pH
Diagnostics
Electrocardiogram
Arrhythmia
s and EKG changes may also occur specific to
Electrolyte
disorders
Low voltage
Prolonged QT
interval
Bradycardia
Management
Inpatient Indications
Suicidal Ideation
with plan
Refusal to eat
Failed outpatient management
Intense supervision required
Severe
Dehydration
Serious renal, hepatic or cardiac complications
Severe weight loss (e.g. Weight <75%
Ideal Body Weight
)
Physical signs
Adults
Weight <75-80% of
Ideal Weight
Heart Rate
< 40 bpm
Blood Pressure
<90/60 mmHg
Glucose
<60 mg/dl
Serum Potassium
<3 mg/dl
Temperature
<96 F
Children
Heart Rate
< 50 bpm
Blood Pressure
<80/50 mmHg
Hypokalemia
Hypophosphatemia
Temperature
<96 F
References
(2000) Am J Psychiatry 157(suppl 1):20 [PubMed]
Campbell (2014) Pediatrics 134(3): 582-92 [PubMed]
Management
Weight gain
Identify initial target weight
Initial weight goal is typically 90% of
Ideal Weight
for age, height and gender
Review weight gain goals
Outpatient: 1 lb (0.45 kg) per week
Inpatient: 2 to 3 lb (0.9 to 1.35 kg) per week
Increase intake slowly
Meal plans are established based on calorie counts
Calories are divided among three meals and two scheduled snacks (monitored)
Calorie counts are not typically discussed with patients
Start at 800 to 1000 kcals per day
Increase by 200 to 300 kcals per 3-4 days
Goal: 3000 to 3500 kcals per day
Adjunctive therapy
Multivitamin
Calcium
supplement
Vitamin D Supplement
Metoclopramide
may reduce bloating with refeeding
Complication:
Refeeding Syndrome
Occurs with early high
Caloric Intake
Monitor
Electrolyte
s in early refeeding
Observe for
Hypophosphatemia
Risk of cardiovascular collapse
Prolonged QT
interval (Risk of sudden death)
Bradycardia
with
Heart Rate
<40 beats per minute
Management
Psychiatric
Multiple modality approach (variable efficacy)
Cognitive Behavioral Therapy
(CBT)
Focus on cognitive distortions around food and weight
Implement experimental model of change
Psychotherapy (e.g. focal psychodynamic therapy)
Re-engage socially
Resume regular physical activities
Increase insight
Reduce distorted body image
Reduce dysfunctional eating habits
Family-Based Treatment (first-line treatment for teens and some young adults)
Parents play a role in assisting weight gain until patient gradually self-manages fully
Maudsley Method is one effective approach
Couturier (2013) Int J Eat Disord 46(1): 3-11 [PubMed]
Mindfulness
activities (e.g. yoga, meditation)
Avoid self-help (ineffective)
Medications used in
Anorexia
Olanzapine
(
Zyprexa
) 10 mg orally daily may be effective for mood and weight gain
Barbarich (2004) J Clin Psychiatry 65(11):1480-2 [PubMed]
Medications for comorbid Depression (not effective for
Anorexia
without
Major Depression
)
Desipramine
Effexor
Selective Serotonin Reuptake Inhibitor
s (
SSRI
)
Medications to avoid
Avoid
Bupropion
(
Wellbutrin
,
Seizure
risk)
Avoid
Drugs That Prolong the QTc Interval
Management
Secondary Amenorrhea
Diagnostics
Follicle Stimulating Hormone
(FSH) low
Luteinizing Hormone
(LH) low
Estrogen
low
No withdrawal bleed on
Progesterone
(
Estrogen
low)
Risks
Osteopenia
Osteoporosis
Pregnancy may occur despite
Amenorrhea
Contraception
recommended for sexually active patients
Gene
ral Management
Menses
resume when >90% of
Ideal Body Weight
Calcium Supplementation
Vitamin D Supplement
ation
Hormonal Therapy
Combination
Estrogen
and
Progesterone
Transdermal 17-beta
Estradiol
100 mcg patch (decreased dose if
Bone Age
<15) AND
Medroxyprogesterone
(
Provera
) 2.5 mg orally daily for 10 days of month
Misra (2011) J Bone Miner Res 26(10): 2430-8 [PubMed]
Oral
Dehydroepiandrosterone
Currently studied for
Osteoporosis Prevention
May prevent bone loss in
Anorexia
Oral Contraceptive
s are not routinely recommended for improving bone mass
Does not prevent
Osteoporosis
Masks normal
Menses
as a marker of regained health
Prognosis
Treatment outcomes
Full recovery: 50%
Partial recovery: 30%
Chronically ill: 20%
Associated with increased mortality (highest of any mental health disorder)
Incidence
of premature death: 10-18%
All cause increased mortality
Relative Risk
: 1.7 to 5.9
Causes of death
Cardiac and metabolic (observe for
Prolonged QT
)
Suicide
Increased Morbidity
Gynecologic Disorders
Osteoporosis
and pathologic
Fracture
s
Mental Health disorders
Cardiovascular disease
Gastrointestinal disease
Resources
Patient Education
Information from your Family Doctor
http://www.familydoctor.org/handouts/063.html
References
(1994) DSM IV, APA, p. 544-5
Renbarger and Pearson (2021) Crit Dec Emerg Med 35(8): 17-23
Bulik (2007) Int J Eating Disord 40:310-20 [PubMed]
Gordon (1999) J Bone Miner Res 14:136-45 [PubMed]
Harrington (2014) Am Fam Physician 91(1): 46-52 [PubMed]
Hobbs (1996) Am Fam Physician, 54(4): 1273-9 [PubMed]
Klein (2021) Am Fam Physician 103(1): 22-32 [PubMed]
Mehler (2001) Ann Intern Med 134:1048-59 [PubMed]
Seidenfeld (2001) Am Fam Physician 64(3):445-50 [PubMed]
Type your search phrase here